Addition of rituximab to fludarabine may prolong progression-free survival and overall survival in patients with previously untreated chronic lymphocytic leukemia: An updated retrospective comparative analysis of CALGB 9712 and CALGB 9011
John C. Byrd
, Kanti Rai
, Bercedis L. Peterson
, Frederick R. Appelbaum
, Vicki A. Morrison
, Jonathan E. Kolitz
, Lois Shepherd
, John D. Hines
, Charles A. Schiffer
, Richard A. Larson
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Addition of rituximab to fludarabine may prolong progression-free survival and overall survival in patients with previously untreated chronic lymphocytic leukemia: An updated retrospective comparative analysis of CALGB 9712 and CALGB 9011'. Together they form a unique fingerprint.